We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Franklin Covey
FC
$203M
| $10.2M | 0.03% |
225,180
+242
| +0.1% | +$12K |
|
527
Fomento Económico Mexicano
FMX
$41.4B
| $10.2M | 0.03% |
+162,822
| New | +$10.3M |
|
528
Cerence
CRNC
$363M
| $10.2M | 0.03% |
648,600
+78,223
| +14% | +$1.76M |
|
529
O-I Glass
OI
$974M
| $10.1M | 0.03% |
778,568
-135,481
| -15% | -$1.83M |
|
|
BLSA
530
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $10M | 0.03% |
1,000,000
| – | – |
|
531
Adaptive Biotechnologies
ADPT
$4.26B
| $9.98M | 0.03% |
1,401,339
+3,806
| +0.3% | +$35.8K |
|
|
OMEG
532
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
| $9.95M | 0.03% |
1,000,000
| – | – |
|
533
Global Payments
GPN
$23.5B
| $9.93M | 0.03% |
91,878
+31,540
| +52% | +$3.89M |
|
534
Lennox International
LII
$12.5B
| $9.92M | 0.03% |
44,550
-536
| -1% | -$128K |
|
|
SWI
535
DELISTED
SolarWinds Corporation Common Stock
SWI
| $9.89M | 0.03% |
1,276,763
+911,383
| +249% | +$8.73M |
|
536
Enviri
NVRI
$606M
| $9.84M | 0.03% |
2,630,550
+1,094,090
| +71% | +$6.06M |
|
537
Masco
MAS
$13.6B
| $9.82M | 0.03% |
210,324
-263,047
| -56% | -$13.7M |
|
538
Byline Bancorp
BY
$1.73B
| $9.69M | 0.03% |
478,526
+117,868
| +33% | +$2.7M |
|
|
SFIX
539
Stitch Fix
SFIX
$392M
| $9.62M | 0.03% |
2,434,344
-424,419
| -15% | -$2.41M |
|
540
Coca-Cola Consolidated
COKE
$13.2B
| $9.56M | 0.03% |
232,240
+11,970
| +5% | +$589K |
|
541
Fortis
FTS
$27.3B
| $9.55M | 0.03% |
251,514
-5,513
| -2% | -$249K |
|
|
FUSN
542
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $9.55M | 0.03% |
3,174,100
+50,000
| +2% | +$125K |
|
543
Littelfuse
LFUS
$10B
| $9.54M | 0.03% |
47,991
-2,186
| -4% | -$522K |
|
544
SPX Corp
SPXC
$8.93B
| $9.53M | 0.03% |
172,629
-2
| -0% | -$114 |
|
545
Fulton Financial
FULT
$4.53B
| $9.52M | 0.03% |
602,652
-29,750
| -5% | -$480K |
|
546
ASML
ASML
$611B
| $9.52M | 0.03% |
22,910
-1,479
| -6% | -$741K |
|
547
Dutch Bros
BROS
$5.79B
| $9.35M | 0.03% |
300,000
| – | – |
|
|
JWN
548
DELISTED
Nordstrom
JWN
| $9.34M | 0.03% |
558,469
+36,930
| +7% | +$771K |
|
549
iShares MSCI EAFE ETF
EFA
$77.9B
| $9.33M | 0.03% |
166,500
-37,700
| -18% | -$2.35M |
|
550
American International
AIG
$39.7B
| $9.21M | 0.03% |
194,043
+1,816
| +0.9% | +$95.4K |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.